ACE2 and viral infectious disease: It is hypothesized that SARS-CoV-2 binding to ACE-2 and the downregulation of ACE-2 would result in the loss of ACE-2 protective qualities in the local RAS system of the lung, regardless of the presence of an active viral infection (45).